Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111277 · ClinicalTrials.gov registry record · NA
MR Guided Focused Ultrasound for Treatment of Neuropathic Pain
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03111277 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 10 participants.
The verdict
NCT03111277, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Neuropathic pain is often a result of direct diseases of peripheral or central nervous system with an estimated prevalence of 8% of adults and this pain is associated with significant consequences because of longer symptom duration and severity than many of the other pain syndromes. Functional brain imaging has revealed that many regions of the brain are engaged by painful events, but specific areas such as the thalamus have been markedly implicated. The purpose of this study is to determine the feasibility and safety of MRI-guided focused ultrasound treatment using the ExAblate Transcranial System in patients suffering from Neuropathic pain. This treatment modality offers non-invasive precise treatment potential for these patients.
Interventions
- DEVICE Experimental: ExAblate Transcranial treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-09-15 |
| Est. Completion | 2022-10-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03111277
The ClinicalTrials.gov registry entry for NCT03111277 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Experimental: ExAblate Transcranial treatment is the first listed.
NCT03111277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03111277 about?
NCT03111277 is a clinical study titled "MR Guided Focused Ultrasound for Treatment of Neuropathic Pain". Neuropathic pain is often a result of direct diseases of peripheral or central nervous system with an estimated prevalence of 8% of adults and this pain is associated with significant consequences because of longer symptom duration and severity than many of the other pain syndromes. Functional brain...
What is the current status of trial NCT03111277?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-09-15. Estimated completion is 2022-10-09.
What interventions are being tested in trial NCT03111277?
The interventions under investigation include: Experimental: ExAblate Transcranial treatment (DEVICE).
Who is sponsoring clinical trial NCT03111277?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.